Your session is about to expire
← Back to Search
Prevention (Elasto Gel Therapy Mittens and Foot Wraps) for Breast Cancer
Study Summary
This trial is investigating whether cryotherapy can help prevent or improve taxane-induced peripheral neuropathy in breast cancer patients.
- Breast Cancer
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is enrollment for this research endeavor open at the present moment?
"Clinicaltrials.gov data reveals that this medical trial, which initially opened for enrolment on January 23rd 2020, is no longer actively seeking patients. Nonetheless, there are presently 2,745 other clinical trials welcoming participants to participate in their studies."
Does this trial accept individuals aged 45 or older?
"According to the predetermined eligibility requirements, potential participants must be at least 18 years old and should not exceed 99."
To whom does the criteria of this experimental research extend?
"80 volunteers aged between 18 and 99, suffering from peripheral neuropathy are needed for this trial. The following prerequisites must be met: diagnosis of breast cancer; 4-6 cycles of paclitaxel or docetaxel administered every 3 weeks over 12-18 week period; no sensory peripheral neuropathy, skin or nail issues upon starting treatment; Eastern Cooperative Oncology Group performance status rating of 0 to 2; self completion (or help with) questionnaires capability as well as signature provided on informed consent form."
Share this study with friends
Copy Link
Messenger